Regulators debate controls for 3D printed skin

Published: 5-Feb-2016

L’Oréal's new R&D partnership to develop 3D printed skin tissues raises issues

You need to be a subscriber to read this article.
Click here to find out more.

As innovation in 3D printing technology continues, the possibility for the 3D printing of human skin for use in the cosmetics industry is becoming increasingly viable. Such skin could be used as an alternative to animal testing of cosmetics and personal care products, and perhaps even used in the human body for cosmetic purposes. But as brands explore the growing possibilities, regulators are also moving to consider how 3D printed skin will be controlled.


The pioneers

In May 2015, L’Oréal USA and California-based 3D bioprinting company Organovo Holdings announced a partnership to develop 3D printed skin tissue.

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Cosmetics Business.

Subscribe now Already a subscriber? Sign in here.

You may also like